Arkolith/Insider Trading/PBYI/Form 4

Auerbach Alan H

President and CEO, Director, 10% OwnerPUMA BIOTECHNOLOGY, INC. (PBYI) · full profile →Form 4 · filed Jan 5, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$186K
Net Open-Market Flow
-$186K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2024Sell(S)41K$4.49$186K6.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-24-000770) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML